175 related articles for article (PubMed ID: 26351161)
41. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
[TBL] [Abstract][Full Text] [Related]
42. Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution.
Davis MT; Potter CB; Walker GM
Int J Pharm; 2018 Jun; 544(1):242-253. PubMed ID: 29689366
[TBL] [Abstract][Full Text] [Related]
43. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
[TBL] [Abstract][Full Text] [Related]
44. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
45. Rheological and solid-state NMR assessments of copovidone/clotrimazole model solid dispersions.
Yang F; Su Y; Zhu L; Brown CD; Rosen LA; Rosenberg KJ
Int J Pharm; 2016 Mar; 500(1-2):20-31. PubMed ID: 26780122
[TBL] [Abstract][Full Text] [Related]
46. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
[TBL] [Abstract][Full Text] [Related]
47. Investigation of miscibility estimation methods between indomethacin and poly(vinylpyrrolidone-co-vinyl acetate).
Pezzoli R; Lyons JG; Gately N; Higginbotham CL
Int J Pharm; 2018 Oct; 549(1-2):50-57. PubMed ID: 30016675
[TBL] [Abstract][Full Text] [Related]
48. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
[TBL] [Abstract][Full Text] [Related]
49. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
50. Numerical simulation of hot-melt extrusion processes for amorphous solid dispersions using model-based melt viscosity.
Bochmann ES; Steffens KE; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2018 Mar; 124():34-42. PubMed ID: 29221654
[TBL] [Abstract][Full Text] [Related]
51. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
52. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
53. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?
Qian F; Huang J; Zhu Q; Haddadin R; Gawel J; Garmise R; Hussain M
Int J Pharm; 2010 Aug; 395(1-2):232-5. PubMed ID: 20562003
[TBL] [Abstract][Full Text] [Related]
54. A preliminary assessment of the impact of hot-melt extrusion on the physico-mechanical properties of a tablet.
Boersen N; Lee TW; Shen XG; Hui HW
Drug Dev Ind Pharm; 2014 Oct; 40(10):1386-94. PubMed ID: 23957611
[TBL] [Abstract][Full Text] [Related]
55. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
[TBL] [Abstract][Full Text] [Related]
56. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
[TBL] [Abstract][Full Text] [Related]
57. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
[TBL] [Abstract][Full Text] [Related]
58. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
[TBL] [Abstract][Full Text] [Related]
59. Impact of Method of Preparation of Amorphous Solid Dispersions on Mechanical Properties: Comparison of Coprecipitation and Spray Drying.
Hou HH; Rajesh A; Pandya KM; Lubach JW; Muliadi A; Yost E; Jia W; Nagapudi K
J Pharm Sci; 2019 Feb; 108(2):870-879. PubMed ID: 30244013
[TBL] [Abstract][Full Text] [Related]
60. Comparison of spray drying, electroblowing and electrospinning for preparation of Eudragit E and itraconazole solid dispersions.
Sóti PL; Bocz K; Pataki H; Eke Z; Farkas A; Verreck G; Kiss É; Fekete P; Vigh T; Wagner I; Nagy ZK; Marosi G
Int J Pharm; 2015 Oct; 494(1):23-30. PubMed ID: 26241751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
